HCA Healthcare, Inc. $HCA Stock Position Reduced by TD Waterhouse Canada Inc.

Key Points

• TD Waterhouse Canada reduced its HCA Healthcare position by 18.2% in the third quarter, selling 2,855 shares and retaining 12,791 shares valued at approximately $5.4 million. Institutional investors and hedge funds collectively own 62.73% of the stock.
• Analyst sentiment remains positive overall, with 16 Buy ratings, seven Holds and one Sell rating. HCA has a consensus rating of “Moderate Buy” and an average price target of $467.61.
• HCA reported quarterly earnings of $7.59 per share and revenue of $20.23 billion, exceeding analyst estimates, while revenue rose 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, equivalent to a 0.7% annual yield.

TD Waterhouse Canada Inc. decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,791 shares of the company's stock after selling 2,855 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in HCA Healthcare were worth $5,416,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $5,069,974,000. Wellington Management Group LLP lifted its stake in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock valued at $1,835,397,000 after buying an additional 799,761 shares during the period. Darsana Capital Partners LP boosted its position in HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company's stock worth $428,879,000 after acquiring an additional 350,000 shares during the last quarter. Legal & General Group Plc purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $410,992,000. Finally, Jupiter Topco LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $371,138,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on HCA. JPMorgan Chase & Co. decreased their price objective on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a report on Thursday, August 20th. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research note on Tuesday, July 7th. Weiss Ratings upgraded HCA Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, October 8th. Morgan Stanley decreased their price target on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating on the stock in a research note on Monday, July 27th. Finally, Royal Bank Of Canada lifted their price target on HCA Healthcare from $435.00 to $496.00 and gave the company an "outperform" rating in a report on Wednesday, October 7th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $467.61.

HCA Healthcare Stock Down 0.7%

Shares of HCA opened at $455.53 on Tuesday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company's fifty day moving average is $427.22 and its two-hundred day moving average is $418.81. The firm has a market cap of $98.62 billion, a PE ratio of 15.25, a price-to-earnings-growth ratio of 1.55 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business's revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the prior year, the firm posted $6.84 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were paid a dividend of $0.78 per share. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.45%.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.